SEC Filings for Eagle Pharmaceuticals Inc. (EGRX)

$ 46.47   -0.01 (-0.02%) Volume: 111.73k 4:00 PM EDT 21-Oct-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)510/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)3409/28/2020
8-KCurrent report pursuant to Section 13 or 15(d)609/24/2020
8-KCurrent report pursuant to Section 13 or 15(d)609/23/2020
8-KCurrent report pursuant to Section 13 or 15(d)3409/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals1009/10/2020
8-KCurrent report pursuant to Section 13 or 15(d)1408/10/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)5208/10/2020
8-KCurrent report pursuant to Section 13 or 15(d)308/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)307/16/2020
8-KCurrent report pursuant to Section 13 or 15(d)507/09/2020
8-KCurrent report pursuant to Section 13 or 15(d)306/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)3606/01/2020
DEFA14AAdditional proxy soliciting materials - definitive405/22/2020
8-KCurrent report pursuant to Section 13 or 15(d)3605/19/2020
<<
First
<
Prev
123456789101112131415